Noxopharm (NOX) Short Interest
Noxopharm (ASX:NOX) had 0.00% of shares reported as short positions as of 24 Aug 2026, representing 4,188 shares. Noxopharm operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Noxopharm
Noxopharm Limited is an Australian clinical-stage drug development company focused on creating innovative treatments for cancer and cytokine release syndrome (septic shock). The company is dedicated to improving patient outcomes through novel therapies and has a pipeline of drug candidates targeting unmet medical needs in oncology and inflammation.
Short position
Noxopharm (ASX:NOX) has 0.00% of its shares on issue reported as short positions as of 24 Aug 2026, or about 4,188 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 2.78% in September 2016. NOX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 38, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4NOX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
NOX Short Interest History
- 30-day change
- +0.00pp
- 90-day change
- +0.00pp
- 1-year change
- +0.00pp
- All-time high
- 2.78% (September 2016)
- All-time low
- 0.00% (July 2025)
Is NOX heavily shorted?
Not especially: 0.00% short interest is modest by ASX standards, ranking #661 of 819 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has NOX's short interest changed recently?
Over the past 30 days Noxopharm's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.
What is the highest NOX's short interest has been?
Since 2016, Noxopharm's short interest peaked at 2.78% in September 2016 and bottomed at 0.00% in July 2025.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2016. See our methodology.
Company
AI-generated research profile of Noxopharm
Latest NOX news
All news- SOF-SKN to progress to extension study in CLE patients
asx · 13 Sept 2026
- Investor Presentation September 2026
asx · 3 Sept 2026
- Novel oligonucleotides data presented at Options Conference
asx · 31 Aug 2026
- Appendix 4E - Preliminary Financial Report
asx · 27 Aug 2026
- New preclinical data supports immuno-oncology approach
asx · 25 Aug 2026
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss NOX
Start a research thread or post the first pulse update